Colobreathe® (colistimethate sodium) Prescribing Information will be available for healthcare professionals via the regional page.
Adverse events should be reported. Reporting forms and information can be obtained from your local licensing partner. Adverse events should also be reported to Essential Pharma on +44 (0)1423 850700 or at essentialpharmaUK@EU.ProPharmaGroup.com.
Essential Pharma Ltd (Malta), Vision Exchange Building, Triq It-Territorjals, Zone 1, Central Business District, Birkirkara CBD 1070, Malta